BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10505717)

  • 1. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms.
    Ikeda M; Wada M; Fujita Y; Takahashi S; Maekawa K; Honjo M
    Growth Horm IGF Res; 2000 Oct; 10(5):248-55. PubMed ID: 11042021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated gene transfer of dominant-negative Smad4 blocks TGF-beta signaling in pancreatic acinar cells.
    Zhang L; Graziano K; Pham T; Logsdon CD; Simeone DM
    Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1247-53. PubMed ID: 11352818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38β MAP kinase as a therapeutic target for pancreatic cancer.
    Singh AK; Pandey R; Gill K; Singh R; Saraya A; Chauhan SS; Yadav S; Pal S; Singh N; Dey S
    Chem Biol Drug Des; 2012 Aug; 80(2):266-73. PubMed ID: 22515544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mitochondria in apoptosis*.
    Wang C; Youle RJ
    Annu Rev Genet; 2009; 43():95-118. PubMed ID: 19659442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Smad2 inhibits proliferation of gingival epithelial cells.
    Shimoe M; Yamamoto T; Shiomi N; Tomikawa K; Hongo S; Yamashiro K; Yamaguchi T; Maeda H; Takashiba S
    J Periodontal Res; 2014 Jun; 49(3):290-8. PubMed ID: 23738652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of fibroblast integrins alpha2 and beta1 in maintaining the structural and mechanical properties of the skin.
    Fujimura T; Moriwaki S; Imokawa G; Takema Y
    J Dermatol Sci; 2007 Jan; 45(1):45-53. PubMed ID: 17118629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase D.
    McDermott M; Wakelam MJ; Morris AJ
    Biochem Cell Biol; 2004 Feb; 82(1):225-53. PubMed ID: 15052340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the TGFβ gene family with microenvironmental features of gastric cancer and prediction of response to immunotherapy.
    Han B; Fang T; Zhang Y; Zhang Y; Gao J; Xue Y
    Front Oncol; 2022; 12():920599. PubMed ID: 36119489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC2 Facilitates Pancreatic Cancer Metastasis.
    Krauß L; Urban BC; Hastreiter S; Schneider C; Wenzel P; Hassan Z; Wirth M; Lankes K; Terrasi A; Klement C; Cernilogar FM; Öllinger R; de Andrade Krätzig N; Engleitner T; Schmid RM; Steiger K; Rad R; Krämer OH; Reichert M; Schotta G; Saur D; Schneider G
    Cancer Res; 2022 Feb; 82(4):695-707. PubMed ID: 34903606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines.
    Safaee S; Fardi M; Hemmat N; Khosravi N; Derakhshani A; Silvestris N; Baradaran B
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33572092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying new targets in leukemogenesis using computational approaches.
    Jayaraman A; Jamil K; Khan HA
    Saudi J Biol Sci; 2015 Sep; 22(5):610-22. PubMed ID: 26288567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico evidence of signaling pathways of notch mediated networks in leukemia.
    Jamil K; Jayaraman A; Rao R; Raju S
    Comput Struct Biotechnol J; 2012; 1():e201207005. PubMed ID: 24688641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways for aberrant angiogenesis in pancreatic cancer.
    Korc M
    Mol Cancer; 2003 Jan; 2():8. PubMed ID: 12556241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer.
    Kleeff J; Friess H; Simon P; Susmallian S; Büchler P; Zimmermann A; Büchler MW; Korc M
    Dig Dis Sci; 1999 Sep; 44(9):1793-802. PubMed ID: 10505717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
    Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.